or Try an Advanced Search...

    Growth Hormone Therapy Stocks List

    Symbol Grade Name % Change
    LUMO F Lumos Pharma, Inc. -4.02
    ASND D Ascendis Pharma A/S -0.16
    NVO A Novo Nordisk A/S 0.01
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Growth Hormone Life Sciences Biopharmaceutical Biotechnology Diabetes Growth Hormone Deficiency Hormones Insulin Peptide Hormones Anti Diabetic Drugs Breakthrough Therapy Diabetes Care Disease Drug Therapies Endocrine System Genetic Diseases Glucagon Like Peptide 1 Haemophilia Hormone Therapy Hypertension

    Related ETFs - A few ETFs which own one or more of the above listed Growth Hormone Therapy stocks.

    Symbol Grade Name Weight
    EDEN B iShares MSCI Denmark Capped ETF 23.27
    OZEM A Roundhill GLP-1 & Weight Loss ETF 20.52
    MEDI D Harbor Health Care ETF 17.84
    THNR B Amplify Weight Loss Drug & Treatment ETF 14.9
    PPH A Market Vectors Pharmaceutical ETF 10.35
    View all Growth Hormone Therapy ETFs...
    Compare ETFs
    Compare MEDI to THNR Compare OZEM to MEDI Compare THNR to PPH

        Growth Hormone Therapy Stocks Recent News

        Date Stock Title
        Jun 15 NVO Novo Nordisk CEO to testify before Senate on Ozempic pricing
        Jun 15 NVO 3 Growth Stocks You Can Buy Right Now Without Any Hesitation
        Jun 14 NVO Employee benefits survey finds marked increase in GLP-1 coverage
        Jun 14 NVO Novo Nordisk (NVO) Advances While Market Declines: Some Information for Investors
        Jun 14 NVO Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy
        Jun 14 NVO Eli Lilly unveils new manufacturing plant for GLP-1 pens
        Jun 14 NVO IBD Sector Leaders: Top Picks To Watch Include Nvidia Stock, Ozempic Maker Novo Nordisk
        Jun 14 NVO Few IBD 50 Stocks In Buy Zones; Netflix Is One
        Jun 14 NVO Pre-diabetes rates increase amidst a renaissance for type 2 diabetes research
        Jun 14 NVO Eli Lilly and Novo Nordisk are a 'duopoly' in GLP-1 market
        Jun 14 NVO Employer coverage for GLP-1s rising amid FDA label expansions: survey
        Jun 14 NVO Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
        Jun 14 NVO Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity Drug
        Jun 12 NVO Market Chatter: Novo Nordisk, Eli Lilly's Weight-Loss Drugs Coverage Dropped by Blue Cross Blue Shield of Michigan
        Jun 12 NVO ASML, Novo Nordisk, Spotify Boast This Sign Of Stock Market Leadership
        Jun 12 NVO GLP-1 obesity drug coverage dropped by Blue Cross Michigan: report
        Jun 12 NVO Bernie Sanders Wants to Subpoena Novo Nordisk Over Wegovy’s Price. What to Know.
        Jun 12 NVO Eli Lilly Runs Up 49% With Expectations For Weight-Loss Sales To Triple
        Jun 12 NVO Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation'
        Jun 11 NVO Update: Novo Nordisk to Face Senate Panel Subpoena Vote Over Ozempic, Wegovy Prices
        Related Industries: Biotechnology
        Related Stock Lists: Growth Hormone Life Sciences Biopharmaceutical Biotechnology Diabetes Growth Hormone Deficiency Hormones Insulin Peptide Hormones Anti Diabetic Drugs Breakthrough Therapy Diabetes Care Disease Drug Therapies Endocrine System Genetic Diseases Glucagon Like Peptide 1 Haemophilia Hormone Therapy Hypertension
        Growth Hormone Therapy

        Growth hormone therapy is a medical treatment that involves the use of growth hormones to treat a variety of conditions, including growth hormone deficiency, Turner syndrome, Prader-Willi syndrome, chronic kidney disease, and other conditions. Growth hormone therapy is typically administered through injections, and it helps to stimulate the body’s natural production of growth hormones. This can help to improve physical growth, muscle mass, bone density, and overall health.

        Browse All Tags